Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA

被引:43
|
作者
Konstantinova, P.
de Vries, W.
Haasnoot, J.
ter Brake, O.
de Haan, P.
Berkhout, B.
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Human Retrovirol, NL-1105 AZ Amsterdam, Netherlands
[2] Viruvat BV, Leiden, Netherlands
关键词
HIV-1; RNA interference; lhRNA;
D O I
10.1038/sj.gt.3302786
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of virus replication by means of RNA interference has been reported for several important human pathogens, including human immunodeficiency virus type 1 (HIV-1). RNA interference against these pathogens has been accomplished by introduction of virus-specific synthetic small interfering RNAs (siRNAs) or DNA constructs encoding short-hairpin RNAs (shRNAs). Their use as therapeutic antiviral against HIV-1 is limited, because of the emergence of viral escape mutants. In order to solve this durability problem, we tested DNA constructs encoding virus-specific long-hairpin RNAs (lhRNAs) for their ability to inhibit HIV-1 production. Expression of lhRNAs in mammalian cells may result in the synthesis of many siRNAs targeting different viral sequences, thus providing more potent inhibition and reducing the chance of viral escape. The lhRNA constructs were compared with in vitro diced double-stranded RNA and a DNA construct encoding an effective nef-specific shRNA for their ability to inhibit HIV-1 production in cells. Our results show that DNA constructs encoding virus-specific lhRNAs are capable of inhibiting HIV-1 production in a sequence-specific manner, without inducing the class I interferon genes.
引用
收藏
页码:1403 / 1413
页数:11
相关论文
共 50 条
  • [21] Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors
    Broström, C
    Visco-Comandini, U
    Yun, ZB
    Sönnerborg, A
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06): : 1542 - 1548
  • [22] DNA constructs expressing long-hairpin RNA (lhRNA) protect Penaeus monodon against White Spot Syndrome Virus
    Krishnan, P.
    Babu, P. Gireesh
    Saravanan, S.
    Rajendran, K. V.
    Chaudhari, Aparna
    VACCINE, 2009, 27 (29) : 3849 - 3855
  • [23] Human immunodeficiency virus type 1 RNA shedding in the female genital tract
    Goulston, C
    McFarland, W
    Katzenstein, D
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 1100 - 1103
  • [24] Viral RNA in the resolution of human immunodeficiency virus type 1 diagnostic serology
    Brown, AE
    Jackson, B
    Fuller, SA
    Sheffield, J
    Cannon, MA
    Lane, JR
    TRANSFUSION, 1997, 37 (09) : 926 - 929
  • [25] Inhibition of virus replication by RNA interference
    Haasnoot, J
    Cupac, D
    Berkhout, B
    JOURNAL OF BIOMEDICAL SCIENCE, 2003, 10 (06) : 607 - 616
  • [26] Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva
    Shugars, DC
    Patton, LL
    Freel, SA
    Gray, LR
    Vollmer, RT
    Eron, JJ
    Fiscus, SA
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (02) : 414 - 420
  • [27] Performance characteristics of quantification assays for human immunodeficiency virus type 1 RNA
    Schmitt, Y
    JOURNAL OF CLINICAL VIROLOGY, 2001, 20 (1-2) : 31 - 33
  • [28] RNA PACKAGING SIGNAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HAYASHI, T
    SHIODA, T
    IWAKURA, Y
    SHIBUTA, H
    VIROLOGY, 1992, 188 (02) : 590 - 599
  • [29] Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments
    Shepard, RN
    Schock, J
    Robertson, K
    Shugars, DC
    Dyer, J
    Vernazza, P
    Hall, C
    Cohen, MS
    Fiscus, SA
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) : 1414 - 1418
  • [30] Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: Effects on virion morphogenesis and RNA maturation
    Moore, Michael D.
    Fu, William
    Soheilian, Ferri
    Nagashima, Kunio
    Ptak, Roger G.
    Pathak, Vinay K.
    Hu, Wei-Shau
    VIROLOGY, 2008, 379 (01) : 152 - 160